Cutaneous Lupus Erythematosus: Subtypes and Treatment
Cutaneous lupus erythematosus (CLE) is a chronic autoimmune skin condition characterized by inflammation and tissue damage resulting from an abnormal immune response. The disease encompasses several subtypes, each with distinct clinical features and treatment approaches, making accurate diagnosis and management crucial for optimal patient outcomes.
Topics: lupus, autoimmune, connective tissue
Overview / Definition Cutaneous lupus erythematosus (CLE) is a form of lupus erythematosus that is primarily characterized by skin manifestations. It can occur in isolation or as a part of systemic lupus erythematosus (SLE). CLE is classified into several subtypes, including discoid lupus erythematosus (DLE), subacute cutaneous lupus erythematosus (SCLE), and acute cutaneous lupus erythematosus (ACLE), each differing in presentation, prognosis, and treatment modalities. Epidemiology Prevalence of CLE is higher in women, with a ratio of approximately 3:1 compared to men. Most commonly diagnosed in individuals aged 15-40 years. Higher incidence in individuals with a family history of autoimmune diseases. Geographic variations exist, with increased prevalence noted in certain ethnic groups, particularly African Americans and Hispanics. Pathophysiology / Mechanism The pathophysiology of CLE involves complex interactions between genetic predisposition, environmental triggers, and immune dysregulation. Key features include: Increased production of autoantibodies, particularly anti-nuclear antibodies (ANAs) and anti-double-stranded DNA antibodies. Activation of the complement system, leading to tissue damage. Influence of ultraviolet (UV) light, which can exacerbate skin lesions by inducing apoptosis in keratinocytes. Impaired clearance of apoptotic cells, contributing to the chronic inflammatory state. Clinical Presentation The clinical presentation of CLE varies by subtype: Discoid Lupus Erythematosus (DLE): Characterized by well-defined, erythematous plaques with a scaling and atrophy, often located on sun-exposed areas such as the face and scalp. Subacute Cutaneous Lupus Erythematosus (SCLE): Presents with erythematous papulosquamous or annular lesions, typically on the trunk and upper extremities, often triggered by sunlight. Acute Cutaneous Lupus Erythematosus (ACLE): Manifests as a butterfly rash across the cheeks and nose, often associated with systemic symptoms of